Name
Human Immunoglobulin (pH4) for Intravenous Injection (IVIG)
Specifications
1.25g/vial (5%, 25ml)
2.5g/vial (5%, 50ml)
5g/vial (5%, 100ml)
Approval Numbers
1.25g/vial (5%, 25ml) - NMPA Approval No. S10980025
2.5g/vial (5%, 50ml) - NMPA Approval No. S10980026
5g/vial (5%, 100ml) - NMPA Approval No. S20013037
Indications
1.Primary Immunodeficiency Diseases (PID) such as X-linked hypoimmunoglobulinemia, common variant immunodeficiency disease, and immunoglobulin G subtype deficiency disease.
2.Secondary Immunodeficiency Diseases such as severe infections and neonatal sepsis.
3.Autoimmune diseases such as idiopathic thrombocytopenic purpura and Kawasaki disease.
EN
